☰

Panagiotis Katsonis, Ph.D. - Publications

Affiliations: 
2006 University of Houston, Houston, TX, United States 
Area:
General Biophysics, Chemical Engineering, Biochemistry
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Tsutakawa SE, Bacolla A, Katsonis P, Bralić A, Hamdan SM, Lichtarge O, Tainer JA, Tsai CL. Decoding Cancer Variants of Unknown Significance for Helicase-Nuclease-RPA Complexes Orchestrating DNA Repair During Transcription and Replication. Frontiers in Molecular Biosciences. 8: 791792. PMID 34966786 DOI: 10.3389/fmolb.2021.791792  0.313
2019 Sharma A, Biswas A, Liu H, Sen S, Paruchuri A, Katsonis P, Lichtarge O, Chand Dakal T, Maulik U, Gromiha MM, Bandyopadhyay S, Ludwig M, Holz FG, Loeffler KU, Herwig-Carl MC. Mutational Landscape of the BAP1 Locus Reveals an Intrinsic Control to Regulate the miRNA Network and the Binding of Protein Complexes in Uveal Melanoma. Cancers. 11. PMID 31635116 DOI: 10.3390/Cancers11101600  0.398
2019 Clark WT, Kasak L, Bakolitsa C, Hu Z, Andreoletti G, Babbi G, Bromberg Y, Casadio R, Dunbrack R, Folkman L, Ford CT, Jones D, Katsonis P, Kundu K, Lichtarge O, et al. Assessment of predicted enzymatic activity of alpha-N-acetylglucosaminidase (NAGLU) variants of unknown significance for CAGI 2016. Human Mutation. PMID 31342580 DOI: 10.1002/Humu.23875  0.373
2019 Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, et al. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Human Mutation. PMID 31322791 DOI: 10.1002/Humu.23874  0.325
2019 Katsonis P, Lichtarge O. CAGI5: Objective performance assessments of predictions based on the evolutionary action equation. Human Mutation. PMID 31317604 DOI: 10.1002/Humu.23873  0.396
2019 Kasak L, Bakolitsa C, Hu Z, Yu C, Rine J, Dimster-Denk DF, Pandey G, De Baets G, Bromberg Y, Cao C, Capriotti E, Casadio R, Van Durme J, Giollo M, Karchin R, ... Katsonis P, et al. Assessing Computational Predictions of the Phenotypic Effect of Cystathionine-beta-Synthase Variants. Human Mutation. PMID 31301157 DOI: 10.1002/Humu.23868  0.389
2019 Cline MS, Babbi G, Bonache S, Cao Y, Casadio R, de la Cruz X, Díez O, Gutiérrez-Enríquez S, Katsonis P, Lai C, Lichtarge O, Martelli PL, Mishne G, Moles-Fernández A, Montalban G, et al. Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants. Human Mutation. PMID 31294896 DOI: 10.1002/Humu.23861  0.352
2019 Zhang J, Kinch LN, Cong Q, Katsonis P, Lichtarge O, Savojardo C, Babbi G, Martelli PL, Capriotti E, Casadio R, Garg A, Pal D, Weile J, Sun S, Verby M, et al. Assessing predictions on fitness effects of missense variants in calmodulin. Human Mutation. PMID 31283071 DOI: 10.1002/Humu.23857  0.368
2019 Monzon AM, Carraro M, Chiricosta L, Reggiani F, Han J, Ozturk K, Wang Y, Miller M, Bromberg Y, Capriotti E, Savojardo C, Babbi G, Martelli PL, Casadio R, Katsonis P, et al. Performance of computational methods for the evaluation of Pericentriolar Material 1 missense variants in CAGI-5. Human Mutation. PMID 31260570 DOI: 10.1002/Humu.23856  0.421
2019 Voskanian A, Katsonis P, Lichtarge O, Pejaver V, Radivojac P, Mooney SD, Capriotti E, Bromberg Y, Wang Y, Miller M, Martelli PL, Savojardo C, Babbi G, Casadio R, Cao Y, et al. Assessing the performance of in-silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer. Human Mutation. PMID 31241222 DOI: 10.1002/Humu.23849  0.343
2019 Savojardo C, Petrosino M, Babbi G, Bovo S, Corbi-Verge C, Casadio R, Fariselli P, Folkman L, Garg A, Karimi M, Katsonis P, Kim PM, Lichtarge O, Martelli PL, Pasquo A, et al. Evaluating the predictions of the protein stability change upon single amino acid substitutions for the FXN CAGI5 challenge. Human Mutation. PMID 31209948 DOI: 10.1002/Humu.23843  0.374
2019 Pejaver V, Babbi G, Casadio R, Folkman L, Katsonis P, Kundu K, Lichtarge O, Martelli PL, Miller M, Moult J, Pal LR, Savojardo C, Yin Y, Zhou Y, Radivojac P, et al. Assessment of methods for predicting the effects of PTEN and TPMT protein variants. Human Mutation. PMID 31184403 DOI: 10.1002/Humu.23838  0.412
2019 Carraro M, Monzon AM, Chiricosta L, Reggiani F, Aspromonte MC, Bellini M, Pagel K, Jiang Y, Radivojac P, Kundu K, Pal LR, Yin Y, Limongelli I, Andreoletti G, Moult J, ... ... Katsonis P, et al. Assessment of patient clinical descriptions and pathogenic variants from gene panel sequences in the CAGI-5 intellectual disability challenge. Human Mutation. PMID 31144778 DOI: 10.1002/Humu.23823  0.364
2019 Clarke CN, Katsonis P, Hsu TK, Koire AM, Silva-Figueroa A, Christakis I, Williams MD, Kutahyalioglu M, Kwatampora L, Xi Y, Lee JE, Koptez ES, Busaidy NL, Perrier ND, Lichtarge O. Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. Journal of the Endocrine Society. 3: 544-559. PMID 30788456 DOI: 10.1210/Js.2018-00043  0.323
2018 Almannai M, Wang J, Dai H, El-Hattab AW, Faqeih EA, Saleh MA, Al Asmari A, Alwadei AH, Aljadhai YI, AlHashem A, Tabarki B, Lines MA, Grange DK, Benini R, Alsaman AS, ... ... Katsonis P, et al. FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance. Molecular Genetics and Metabolism. PMID 30177229 DOI: 10.1016/J.Ymgme.2018.07.014  0.325
2017 Otaify GA, Whyte MP, Gottesman GS, McAlister WH, Eric Gordon J, Hollander A, Andrews MV, El-Mofty SK, Chen WS, Veis DV, Stolina M, Woo AS, Katsonis P, Lichtarge O, Zhang F, et al. Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5). Bone. 107: 161-171. PMID 29175271 DOI: 10.1016/J.Bone.2017.11.012  0.319
2017 Chun YS, Passot G, Yamashita S, Nusrat M, Katsonis P, Loree JM, Conrad C, Tzeng CD, Xiao L, Aloia TA, Eng C, Kopetz SE, Lichtarge O, Vauthey JN. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Annals of Surgery. PMID 28767562 DOI: 10.1097/Sla.0000000000002450  0.309
2017 Katsonis P, Lichtarge O. Objective assessment of the evolutionary action equation for the fitness effect of missense mutations across CAGI blinded contests. Human Mutation. PMID 28544059 DOI: 10.1002/Humu.23266  0.423
2017 Carraro M, Minervini G, Giollo M, Bromberg Y, Capriotti E, Casadio R, Dunbrack R, Elefanti L, Fariselli P, Ferrari C, Gough J, Katsonis P, Leonardi E, Lichtarge O, Menin C, et al. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI. Human Mutation. PMID 28440912 DOI: 10.1002/Humu.23235  0.373
2017 Xu Q, Tang Q, Katsonis P, Lichtarge O, Jones D, Bovo S, Babbi G, Martelli PL, Casadio R, Lee GR, Seok C, Fenton AW, Dunbrack RL. Benchmarking predictions of allostery in liver pyruvate kinase in CAGI4. Human Mutation. PMID 28370845 DOI: 10.1002/Humu.23222  0.405
2017 Koire A, Kim YW, Wang J, Katsonis P, Jin H, Lichtarge O. Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction. Plos One. 12: e0174766. PMID 28350864 DOI: 10.1371/Journal.Pone.0174766  0.4
2017 Gallion J, Koire A, Katsonis P, Schoenegge AM, Bouvier M, Lichtarge O. Predicting phenotype from genotype: Improving accuracy through more robust experimental and computational modeling. Human Mutation. PMID 28230923 DOI: 10.1002/Humu.23193  0.354
2016 Bocchini CE, Nahmod K, Katsonis P, Kim S, Kasembeli MM, Freeman A, Lichtarge O, Makedonas G, Tweardy DJ. Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome. Blood. PMID 27799162 DOI: 10.1182/Blood-2016-02-702373  0.352
2016 Li Z, Gonzalez CL, Wang B, Zhang Y, Mejia O, Katsonis P, Lichtarge O, Myers JN, El-Naggar AK, Caulin C. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H). The Journal of Pathology. PMID 27447534 DOI: 10.1002/Path.4770  0.322
2015 Mullany LK, Wong KK, Marciano DC, Katsonis P, King-Crane ER, Ren YA, Lichtarge O, Richards JS. Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival. Neoplasia (New York, N.Y.). 17: 789-803. PMID 26585234 DOI: 10.1016/J.Neo.2015.10.003  0.309
2015 Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, et al. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Research. 75: 1205-15. PMID 25691460 DOI: 10.1158/0008-5472.Can-14-2729  0.38
2015 Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, et al. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Research. 75: 1527-36. PMID 25634208 DOI: 10.1158/0008-5472.Can-14-2735  0.373
2015 Osman AA, Monroe MM, Ortega Alves MV, Patel AA, Katsonis P, Fitzgerald AL, Neskey DM, Frederick MJ, Woo SH, Caulin C, Hsu TK, McDonald TO, Kimmel M, Meyn RE, Lichtarge O, et al. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence. Molecular Cancer Therapeutics. 14: 608-19. PMID 25504633 DOI: 10.1158/1535-7163.Mct-14-0735-T  0.341
2014 Katsonis P, Koire A, Wilson SJ, Hsu TK, Lua RC, Wilkins AD, Lichtarge O. Single nucleotide variations: biological impact and theoretical interpretation. Protein Science : a Publication of the Protein Society. 23: 1650-66. PMID 25234433 DOI: 10.1002/Pro.2552  0.393
2014 Katsonis P, Lichtarge O. A formal perturbation equation between genotype and phenotype determines the Evolutionary Action of protein-coding variations on fitness. Genome Research. 24: 2050-8. PMID 25217195 DOI: 10.1101/Gr.176214.114  0.394
2014 Marciano DC, Lua RC, Katsonis P, Amin SR, Herman C, Lichtarge O. Negative feedback in genetic circuits confers evolutionary resilience and capacitance. Cell Reports. 7: 1789-95. PMID 24910431 DOI: 10.1016/J.Celrep.2014.05.018  0.329
2014 Lua RC, Marciano DC, Katsonis P, Adikesavan AK, Wilkins AD, Lichtarge O. Prediction and redesign of protein-protein interactions. Progress in Biophysics and Molecular Biology. 116: 194-202. PMID 24878423 DOI: 10.1016/J.Pbiomolbio.2014.05.004  0.332
2013 Rababa'h A, Craft JW, Wijaya CS, Atrooz F, Fan Q, Singh S, Guillory AN, Katsonis P, Lichtarge O, McConnell BK. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP). Journal of Molecular Biology. 425: 3277-88. PMID 23806656 DOI: 10.1016/J.Jmb.2013.06.014  0.352
2011 Schaaf CP, Koster J, Katsonis P, Kratz L, Shchelochkov OA, Scaglia F, Kelley RI, Lichtarge O, Waterham HR, Shinawi M. Desmosterolosis-phenotypic and molecular characterization of a third case and review of the literature. American Journal of Medical Genetics. Part A. 155: 1597-604. PMID 21671375 DOI: 10.1002/Ajmg.A.34040  0.336
2011 Häberle J, Shchelochkov OA, Wang J, Katsonis P, Hall L, Reiss S, Eeds A, Willis A, Yadav M, Summar S, Lichtarge O, Rubio V, Wong LJ, Summar M. Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Human Mutation. 32: 579-89. PMID 21120950 DOI: 10.1002/Humu.21406  0.396
2010 Wong L, Shaibani A, Shchelochkov OA, Zhang S, Katsonis P, Lichtarge O, Shinawi M. 114 Expanding clinical spectrum of RRM2B mutations to include MNGIE Mitochondrion. 10: 232. DOI: 10.1016/J.Mito.2009.12.106  0.334
2007 Gliko O, Pan W, Katsonis P, Neumaier N, Galkin O, Weinkauf S, Vekilov PG. Metastable liquid clusters in super- and undersaturated protein solutions. The Journal of Physical Chemistry. B. 111: 3106-14. PMID 17388477 DOI: 10.1021/Jp068827O  0.559
2006 Katsonis P, Brandon S, Vekilov PG. Corresponding-states laws for protein solutions. The Journal of Physical Chemistry. B. 110: 17638-44. PMID 16942109 DOI: 10.1021/Jp062698U  0.539
2006 Brandon S, Katsonis P, Vekilov PG. Multiple extrema in the intermolecular potential and the phase diagram of protein solutions. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 73: 061917. PMID 16906874 DOI: 10.1103/Physreve.73.061917  0.527
Show low-probability matches.